Sensitivity and specificity of the high fluorescent lymphocyte count-gate on the Sysmex XE-5000 hematology analyzer for detection of peripheral plasma cells

Author(s):  
Edwin van Mirre ◽  
Gert Jan Vrielink ◽  
Nicole Tjon-a-Tsoi ◽  
Henriët Hendriks ◽  
Wim de Kieviet ◽  
...  
Author(s):  
Nurmalia PS ◽  
N. Suci W ◽  
Imam BW

Systemic Inflammatory Response Syndrome (SIRS) mempunyai kebahayaan tinggi terjadi sepsis dan kematian. Nilai jumlahkeseluruhan leukosit merupakan salah satu peramal pasien SIRS dengan bakteriemia. Pemeriksaan jumlah monosit, angka bandinglimfosit Monocyte-Lymphocyte Ratio (MLR), Neutrophil-Lymphocyte Count Ratio (NLCR) dapat diketahui dengan pemeriksaan leukosit.Presepsin telah diteliti untuk mencerminkan kondisi sepsis. Penelitian ini bertujuan untuk mengetahui keberadaan hubungan jumlahmonosit, MLR dan NLCR dengan presepsin di SIRS lewat pembuktian. Ada 34 pasien SIRS di ICU RSUP Dr. Kariadi, diambil secaraberturutan antara selama bulan Januari−Februari 2014. Pemeriksaan darah rutin dengan hematology analyzer. MLR dan NLCR dihitung secara manual. Kadar presepsin ditentukan dengan metode Chemiluminescent Enzyme Immunoassay (CLEIA). Uji kenasabanPearson untuk hubungan MLR dan NLCR dengan presepsin. Uji kenasaban Spearman untuk jumlah monosit dengan presepsin. Kadarpresepsin subjek penelitian 286–15687 pg/mL. Terdapat 23(67,8%) subjek yang mempunyai jumlah monosit dalam rentang nilai rujukan.24(70,6%) dan memiliki jumlah neutrofil absolut lebih besar dari rentang nilai rujukan, sedangkan 21(61,8%) mempunyai jumlahlimfosit absolut dalam rentang nilai rujukan. Hubungan jumlah monosit dengan presepsin mempunyai nilai r= -0,204; p=0,247;yang terkait MLR dengan presepsin r=0,163; p=0,358; sedangkan NLCR dengan presepsin r=0,345; p=0,046. Didasari telitian ini,dapat disimpulkan tidak terdapat hubungan bermakna antara jumlah monosit dan MLR dengan presepsin, selain itu didapatkan pulahubungan positif berarti antara NLCR dan presepsin di SIRS.


2016 ◽  
Vol 90 (6) ◽  
pp. 531-537 ◽  
Author(s):  
Evdoxia Gounari ◽  
Vasiliki Tsavdaridou ◽  
Triantafyllia Koletsa ◽  
Androula Nikolaidou ◽  
Georgia Kaiafa ◽  
...  

Blood ◽  
2010 ◽  
Vol 116 (21) ◽  
pp. 2985-2985
Author(s):  
Pingping Qu ◽  
Jeff Haessler ◽  
John Shaughnessy ◽  
John Crowley ◽  
Bart Barlogie

Abstract Abstract 2985 Background: The prognosis of patients with MM is best captured by GEP-defined risk, distinguishing ~15% of patients with a median overall survival (OS) in TT2 of ~2yr as opposed to >10yr in low-risk disease. Serum LDH elevation has remained an independent adverse feature, along with the presence of metaphase cytogenetic abnormalities (CA). Here we examined whether GEP features within CD138-selected plasma cells can identify MM-associated serum LDH elevation and CA. Patients and Methods: The training set consisted of 621 cases and the test set consisted of 325 TT patients who had both baseline clinical and GEP data from whole genome Affymetrix U133Plus2.0 microarrays on CD138-enriched plasma cells. Using the training data and the scoring approach described in Shaughnessy et al (2007), we defined a GEP score based on 50 genes to predict serum LDH >190U/L and a GEP score with 15 genes to predict the presence of CA. The gene scores were then tested in univariate and multivariate Cox regression models to assess their clinical utilities in both training and test sets. Results: In the training set, sensitivity and specificity of the GEP 50-gene score for serum LDH >190 were 65% and 76%, respectively; those of the GEP 15-gene score predicting CA were 75% and 78%, respectively. While both GEP scores were significantly associated with overall and event-free survival (p < .001), they were not selected in multivariate stepwise Cox regression analysis. However, the gene scores seem comparable to the clinical variables they try to predict. When serum LDH >190 and CA were replaced by the GEP scores in multivariate models, both gene scores were significant at the .1 level, and the R-squared (R2) statistic decreased by only 2.4% (Table 1). In the test set, sensitivity and specificity of the GEP 50-gene score for serum LDH >190 were 59% and 71%, respectively. Those of the GEP 15-gene score for CA were 58% and 70%, respectively. The GEP scores behaved similarly overall as in the training set with the LDH gene score showing a little higher association than the CA gene score (p<.01 for the GEP CA score and p<.001 for the GEP LDH score). In multivariate stepwise Cox regression, only CA was selected, and when CA was replaced with the GEP CA score (or GEP LDH score), the R-squared statistic decreased by 4.6% (or 1.9%). Conclusions: In summary, we conclude that the GEP scores for LDH and CA are highly comparable to their corresponding clinical variables in terms of survival prediction capability. Our future research will focus on refining our gene selection procedure to achieve higher prediction accuracy, studying the molecular features of selected genes and, based on GEP data, building a predictive model that is at least as powerful as if only clinical variables were used in the model. Disclosures: No relevant conflicts of interest to declare.


2017 ◽  
Vol 2017 ◽  
pp. 1-6 ◽  
Author(s):  
Louis Boafo Kwantwi ◽  
Bismark Kwame Tunu ◽  
Daniel Boateng ◽  
Dan Yedu Quansah

Background. In view of the lack of evidence on the possibility of an economically viable, easy, and readily available biomarker to substitute the traditional role of CD4 counts in HIV disease progression, this study seeks to investigate the potential use of body mass index (BMI), haemoglobin (Hb), and total lymphocyte count (TLC) as surrogate biomarkers for monitoring the disease. Methods. This cross-sectional study was undertaken at the antiretroviral clinic (ART) of the Bomso Hospital, Kumasi, Ghana. We recruited 384 individuals who were 18 years or older and confirmed HIV seropositive patients. Blood samples were assayed for TLC and Hb. Weight and height were determined and BMI was calculated. Result. At a cut-off point of 12.15 g/dL, Hb had sensitivity and specificity of 73.9% and 56.8%, respectively, whereas BMI had 69.6% and 80.1% sensitivity and specificity, respectively. The sensitivity and specificity were also 100% among the studied participants at a cut-off point of 1200 mm−3 for TLC. There was a significant positive correlation between CD4 count and Hb (rho 0.262, p=0.0001), BMI (rho 0.301, p=0.0001), and TLC (rho 0.834, p=0.0001). Conclusion. The study demonstrates that TLC, Hb, and BMI may provide some useful prognostic information independent of that provided by CD4 count.


Blood ◽  
2011 ◽  
Vol 118 (21) ◽  
pp. 4121-4121
Author(s):  
Victor H Jimenez-Zepeda ◽  
Donna E. Reece ◽  
Suzanne Trudel ◽  
Christine Chen ◽  
Norman Franke ◽  
...  

Abstract Abstract 4121 Post-Autologous stem cell transplant (ASCT) studies have demonstrated that early absolute lymphocyte count (ALC) recovery is associated with prolonged survival in some hematological malignancies. Peripheral blood lymphocytes from Multiple Myeloma (MM) were shown to have direct anti-MM activity by proliferative and cytotoxic responses to autologous and allogeneic myeloma plasma cells Disclosures: Jimenez-Zepeda: J & J: Honoraria. Reece:Bristol, Meyers, Squibb: Honoraria, Research Funding; Celgene: Honoraria, Research Funding; Janssen: Honoraria, Research Funding; Johnson&Johnson: Research Funding; Merck: Honoraria, Research Funding; Otsuka: Honoraria, Research Funding; Millennium: Research Funding; Amgen: Honoraria. Chen:Celgene Corporation: Consultancy, Honoraria, Research Funding. Kukreti:Celgene: Honoraria.


Author(s):  
Mary Boulanger ◽  
Emily Molina ◽  
Kunbo Wang ◽  
Thomas Kickler ◽  
Yanxun Xu ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Tomasz Karauda ◽  
Kamil Kornicki ◽  
Amer Jarri ◽  
Adam Antczak ◽  
Joanna Miłkowska-Dymanowska ◽  
...  

AbstractExacerbations of Chronic Obstructive Pulmonary Disease (AECOPDs) are one of the most important clinical aspects of the disease, and when requiring hospital admission, they significantly contribute to mortality among COPD patients. Our aim was to assess the role of eosinopenia and neutrophil-to-lymphocyte count (NLR) as markers of in-hospital mortality and length of hospitalization (LoH) among patients with ECOPD requiring hospitalization. We included 275 patients. Eosinopenia was associated with in-hospital deaths only when coexisted with lymphocytopenia, with the specificity of 84.4% (95% CI 79.6–88.6%) and the sensitivity of 100% (95% CI 35.9–100%). Also, survivors presented longer LoH (P < 0.0001). NLR ≥ 13.2 predicted in-hospital death with the sensitivity of 100% (95% CI 35.9–100%) and specificity of 92.6% (95% CI 88.8–95.4%), however, comparison of LoH among survivors did not reach statistical significance (P = 0.05). Additionally, when we assessed the presence of coexistence of eosinopenia and lymphocytopenia first, and then apply NLR, sensitivity and specificity in prediction of in-hospital death was 100% (95% CI 35.9–100) and 93.7% (95% CI 90.1–96.3), respectively. Moreover, among survivors, the occurrence of such pattern was associated with significantly longer LoH: 11 (7–14) vs 7 (5–10) days (P = 0.01). The best profile of sensitivity and specificity in the prediction of in-hospital mortality in ECOPD can be obtained by combined analysis of coexistence of eosinopenia and lymphocytopenia with elevated NLR. The occurrence of a such pattern is also associated with significantly longer LoH among survivors.


2017 ◽  
Vol 142 (1) ◽  
pp. 83-88 ◽  
Author(s):  
Oh Joo Kweon ◽  
Mi-Kyung Lee ◽  
Hye Ryoun Kim

Context.— In the XN series of hematology analyzers (Sysmex, Kobe, Japan), the probability of the presence of abnormal cells is indicated by flags based on Q values. Objective.— To evaluate the Q value performance of the Sysmex XN-20 modular analyzer. Design.— The interinstrumental concordance, intrainstrumental precision, and diagnostic accuracy of Q values, with tested flags of “blasts/abnormal lymphocytes,” “atypical lymphocytes,” and “blasts,” were investigated. Results.— Absolute concordance rates in flagging between 2 analyzers ranged from 69.8% to 80.8%, and κ values ranged from 0.43 to 0.61. In samples with absolute related cell counts lower than 100/μL, the values ranged from 0.31 to 0.52. For intrainstrumental precision, standard deviations ranged from 4.8 to 23.9 for the blasts/abnormal lymphocytes, from 18.7 to 59.1 for the blasts, and from 11.0 to 23.0 for the atypical lymphocytes. Using a default Q value cutoff, diagnostic accuracy values based on the area under the curve, sensitivity, and specificity were, respectively, 0.910, 90.9%, and 72.2% for blasts/abnormal lymphocytes; 0.927, 84.9%, and 89.8% for blasts; and 0.865, 74.4%, and 84.9% for atypical lymphocytes. The diagnostic accuracy of Q values was much lower in samples with absolute related cell counts lower than 100/μL than in those 100/μL or higher. Conclusions.— Q values of the Sysmex XN-20 analyzer were found to be imprecise and irreproducible, especially with samples containing a small number of pathologic cells. Adjustments in the Q value threshold may help in the detection of these cells.


2012 ◽  
Vol 2012 ◽  
pp. 1-5 ◽  
Author(s):  
Yasufumi Masaki ◽  
Nozomu Kurose ◽  
Motohisa Yamamoto ◽  
Hiroki Takahashi ◽  
Takako Saeki ◽  
...  

IgG4-related disease is a new disease classification established in Japan in the 21st century. Patients with IgG4-related disease display hyper-IgG4-gammaglobulinemia, massive infiltration of IgG4+ plasma cells into tissue, and good response to glucocorticoids. Since IgG4 overexpression is also observed in other disorders, it is necessary to diagnose IgG4-related disease carefully and correctly. We therefore sought to determine cutoff values for serum IgG4 and IgG4/IgG and for IgG4+/IgG+ plasma cells in tissue diagnostic of IgG4-related disease.Patients and Methods. We retrospectively analyzed serum IgG4 concentrations and IgG4/IgG ratio and IgG4+/IgG+ plasma cell ratio in tissues of 132 patients with IgG4-related disease and 48 patients with other disorders.Result. Serum IgG4 >135  mg/dl demonstrated a sensitivity of 97.0% and a specificity of 79.6% in diagnosing IgG4-related disease, and serum IgG4/IgG ratios >8% had a sensitivity and specificity of 95.5% and 87.5%, respectively. IgG4+cell/IgG+ cell ratio in tissues >40% had a sensitivity and specificity of 94.4% and 85.7%, respectively. However, the number of IgG4+ cells was reduced in severely fibrotic parts of tissues.Conclusion. Although a recent unanimous consensus of all relevant researchers in Japan recently established the diagnostic criteria for IgG4-related disease, findings such as ours indicate that further discussion is needed.


Sign in / Sign up

Export Citation Format

Share Document